家禽用ワクチンの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

家禽用ワクチンの世界市場規模は、2024年の25億6,000万米ドルから2033年には50億6,000万米ドルに成長し、2026～2033年の予測期間中に7.85%の堅調な年間平均成長率（CAGR）を示すと予測されます。

健康で病気のない家禽の生産に対する需要が世界的に高まり続けていることから、家禽用ワクチン市場は大きな成長を遂げています。ワクチン接種は家禽の健康管理において極めて重要な要素であり、鳥インフルエンザ、ニューカッスル病、伝染性気管支炎などの疾病の発生予防に役立っています。食品の安全性に対する意識の高まりと、サステイナブル養鶏プラクティスの必要性に伴い、効果的なワクチンに対する需要は拡大すると予想されます。市場の発展に伴い、研究開発、製品の有効性、規制遵守を重視することは、信頼性の高いワクチン接種ソリューションを求める養鶏業者を惹きつける上で極めて重要となります。

さらに、ワクチン技術の進歩が家禽用ワクチンの能力を高めています。遺伝子組換えワクチン、弱毒生ワクチン、不活化ワクチンなどの革新的技術により、メーカー各社は予防効果の向上と副作用の軽減を実現した製品を開発できるようになっています。水性ワクチンやエアロゾルワクチンのようなデリバリーシステムの統合もまた、より効率的な投与と家禽集団へのより良い浸透を可能にし、人気を集めています。家禽用ワクチン市場が成長を続ける中、技術革新と消費者の関与に焦点を当てることは、将来の軌道を形成する上で重要な役割を果たすと考えられます。

さらに、バイオセキュリティ対策と動物福祉の動向の高まりが、家禽用ワクチン市場に影響を与えています。生産者が疾病リスクの最小化と家禽群の健康増進を目指す中、こうした目標に合致したワクチンへの需要が高まっています。この変化は、家禽の健康と生産性を促進するワクチン接種の利点を強調するマーケティングと流通戦略への投資をメーカーに促しています。このように、家禽用ワクチン市場の将来は、家禽産業の進化するニーズに対応するため、品質、イノベーション、ワクチン接種ソリューションの継続的改善に取り組むことが特徴となっています。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：定義、分類、産業の現状に関する概要など、市場に関する詳細なイントロダクション。

市場力学：市場成長に影響を与える主要促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の開発と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 家禽用ワクチン産業分析

• イントロダクション：市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 産業動向
• ポーターのファイブフォース分析
• 市場の魅力分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原料分析
  • 原料リスト
  • 原料メーカー一覧
  • 主要原料の価格動向
• 潜在的バイヤーリスト

第5章 マーケティングチャネル

• 直接マーケティング
• 間接マーケティング
• マーケティングチャネル発展動向

第6章 家禽用ワクチンの世界市場分析：用途別

• 用途別概要
• 実績データと予測データ
• 用途別分析
• ブロイラー
• レイヤー
• ブリーダー

第7章 家禽用ワクチンの世界市場分析：製品別

• 製品別概要
• 実績データと予測データ
• 製品別分析
• 弱毒生ワクチン
• 不活化ワクチン
• サブユニットワクチン
• DNAワクチン
• 組み換えワクチン

第8章 家禽用ワクチンの世界市場分析：疾病タイプ別

• 疾病タイプ別概要
• 実績データと予測データ
• 疾病タイプ別分析
• 感染性気管支炎
• 感染性滑液包炎
• 感染性喉頭気管炎
• 卵落下症候群
• アデノウイルス
• アヒルウイルス性腸炎
• 封入体肝炎
• コクシジウム症
• 鳥インフルエンザ
• マレック病
• ニューカッスル病
• サルモネラ
• 鳥脳脊髄炎
• 家禽コレラ

第9章 家禽用ワクチンの世界市場分析：地域別

• 地域別展望販売分析
• イントロダクション売上分析
• 北米の売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米：国別
  • 米国
  • カナダ
  • メキシコ
• 欧州の売上分析
  • 概要、実績と予測
  • 欧州：セグメント別
  • 欧州：国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他の欧州
• アジア太平洋の売上分析
  • 概要、実績と予測
  • アジア太平洋：セグメント別
  • アジア太平洋：国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • その他のアジア太平洋
• ラテンアメリカの売上分析
  • 概要、実績と予測
  • ラテンアメリカ：セグメント別
  • ラテンアメリカ：国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他のラテンアメリカ
• 中東・アフリカの売上分析
  • 概要、実績と予測
  • 中東・アフリカ：セグメント別
  • 中東・アフリカ：国別
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他の中東・アフリカ

第10章 家禽用ワクチン企業の競合情勢

• 家禽用ワクチン市場競合
• パートナーシップ/提携/協定
• 合併・買収
• 新製品上市
• その他の開発

第11章 企業プロファイル

• 上位10社のシェア分析
• 市場集中度
• Boehringer Ingelheim International GmbH
• Ceva
• Zoetis
• Elanco
• Intervet Inc.
• Merck Co. Inc.
• Hester Biosciences Limited
• Vaxxinova International BV
• Venkys India
• Calier
• KM Biologics
• Phibro Animal Health Corporation

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Application (USD MN)
• Broiler Market Sales by Geography (USD MN)
• Layer Market Sales by Geography (USD MN)
• Breeder Market Sales by Geography (USD MN)
• Analysis Market by Product (USD MN)
• Attenuated Live Vaccines Market Sales by Geography (USD MN)
• Inactivated Vaccines Market Sales by Geography (USD MN)
• Subunit Vaccines Market Sales by Geography (USD MN)
• DNA Vaccines Market Sales by Geography (USD MN)
• Recombinant Vaccines Market Sales by Geography (USD MN)
• Analysis by Disease Type (USD MN)
• Infectious Bronchitis Market Sales by Geography (USD MN)
• Infectious Bursal Diseases Market Sales by Geography (USD MN)
• Infectious Laryngotracheitis Market Sales by Geography (USD MN)
• Egg Drop Syndrome Market Sales by Geography (USD MN)
• Adenovirus Market Sales by Geography (USD MN)
• Duck Viral Enteritis Market Sales by Geography (USD MN)
• Inclusion Body Hepatitis Market Sales by Geography (USD MN)
• Coccidiosis Market Sales by Geography (USD MN)
• Avian Influenza Market Sales by Geography (USD MN)
• Marek's Disease Market Sales by Geography (USD MN)
• Newcastle Disease Market Sales by Geography (USD MN)
• Salmonella Market Sales by Geography (USD MN)
• Avian Encephalomyelitis Market Sales by Geography (USD MN)
• Fowl Cholera Market Sales by Geography (USD MN)
• Global Poultry Vaccines Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Poultry Vaccines Report
• Market Research Process
• Market Research Methodology
• Global Poultry Vaccines Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Disease Type
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Application (USD MN)
• Broiler Market Sales by Geography (USD MN)
• Layer Market Sales by Geography (USD MN)
• Breeder Market Sales by Geography (USD MN)
• Global Market Analysis by Product (USD MN)
• Attenuated Live Vaccines Market Sales by Geography (USD MN)
• Inactivated Vaccines Market Sales by Geography (USD MN)
• Subunit Vaccines Market Sales by Geography (USD MN)
• DNA Vaccines Market Sales by Geography (USD MN)
• Recombinant Vaccines Market Sales by Geography (USD MN)
• Global Market Analysis by Disease Type (USD MN)
• Infectious Bronchitis Market Sales by Geography (USD MN)
• Infectious Bursal Diseases Market Sales by Geography (USD MN)
• Infectious Laryngotracheitis Market Sales by Geography (USD MN)
• Egg Drop Syndrome Market Sales by Geography (USD MN)
• Adenovirus Market Sales by Geography (USD MN)
• Duck Viral Enteritis Market Sales by Geography (USD MN)
• Inclusion Body Hepatitis Market Sales by Geography (USD MN)
• Coccidiosis Market Sales by Geography (USD MN)
• Avian Influenza Market Sales by Geography (USD MN)
• Marek's Disease Market Sales by Geography (USD MN)
• Newcastle Disease Market Sales by Geography (USD MN)
• Salmonella Market Sales by Geography (USD MN)
• Avian Encephalomyelitis Market Sales by Geography (USD MN)
• Fowl Cholera Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Global Poultry Vaccines Market size is anticipated to grow from USD 2.56 Billion in 2024 to USD 5.06 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.85% during the forecast period of 2026 to 2033.

The poultry vaccines market is experiencing significant growth as the demand for healthy and disease-free poultry production continues to rise globally. Vaccination is a crucial component of poultry health management, helping to prevent outbreaks of diseases such as avian influenza, Newcastle disease, and infectious bronchitis. With the increasing awareness of food safety and the need for sustainable poultry farming practices, the demand for effective vaccines is expected to grow. As the market evolves, the emphasis on research and development, product efficacy, and regulatory compliance will be crucial in attracting poultry producers seeking reliable vaccination solutions.

Moreover, advancements in vaccine technology are enhancing the capabilities of poultry vaccines. Innovations such as recombinant vaccines, live attenuated vaccines, and inactivated vaccines are enabling manufacturers to develop products that offer improved protection and reduced side effects. The integration of delivery systems, such as water-based and aerosol vaccines, is also gaining traction, allowing for more efficient administration and better uptake among poultry populations. As the poultry vaccines market continues to grow, the focus on innovation and consumer engagement will play a vital role in shaping its future trajectory.

In addition, the growing trend of biosecurity measures and animal welfare is influencing the poultry vaccines market. As producers seek to minimize disease risks and enhance the health of their flocks, there is a rising demand for vaccines that align with these goals. This shift is prompting manufacturers to invest in marketing and distribution strategies that highlight the benefits of vaccination in promoting poultry health and productivity. The future of the poultry vaccines market is thus characterized by a commitment to quality, innovation, and the continuous improvement of vaccination solutions to meet the evolving needs of the poultry industry.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

• Modified or Attenuated (Live)
• Inactivated (Killed)
• Recombinants

By Dosage Form

• Liquid Vaccine
• Freeze Dried Vaccine
• Duct

By Disease Type

• Newcastle Disease
• Marek's Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Others

By Application

• Breeder
• Broiler
• Layer

By End User

• Hospitals
• Poultry Vaccination Centres
• Poultry Firms
• COMPANIES PROFILED
• Zoetis
• Boehringer Ingelheim
• Merck Animal Health
• Elanco Animal Health
• Dechra Pharmaceuticals
• Phibro Animal Health
• Hester Biosciences
• Novartis Animal Health
• Ceva Sante Animale
• Venky's India Ltd.
• The above list can be customized.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . POULTRY VACCINES INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Application
  • 3.7.2 Market Attractiveness Analysis By Product
  • 3.7.3 Market Attractiveness Analysis By Disease Type
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers

5. MARKETING CHANNEL

• 5.1. Direct Marketing
• 5.2. Indirect Marketing
• 5.3. Marketing Channel Development Trend

6 . GLOBAL POULTRY VACCINES MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Broiler Historic and Forecast Sales by Regions
• 6.5 Layer Historic and Forecast Sales by Regions
• 6.6 Breeder Historic and Forecast Sales by Regions

7 . GLOBAL POULTRY VACCINES MARKET ANALYSIS BY PRODUCT

• 7.1 Overview by Product
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Product
• 7.4 Attenuated Live Vaccines Historic and Forecast Sales by Regions
• 7.5 Inactivated Vaccines Historic and Forecast Sales by Regions
• 7.6 Subunit Vaccines Historic and Forecast Sales by Regions
• 7.7 DNA Vaccines Historic and Forecast Sales by Regions
• 7.8 Recombinant Vaccines Historic and Forecast Sales by Regions

8 . GLOBAL POULTRY VACCINES MARKET SALES ANALYSIS BY DISEASE TYPE

• 8.1 Overview by Disease Type
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Disease Type
• 8.4 Infectious Bronchitis Historic and Forecast Sales by Regions
• 8.5 Infectious Bursal Diseases Historic and Forecast Sales by Regions
• 8.6 Infectious Laryngotracheitis Historic and Forecast Sales by Regions
• 8.7 Egg Drop Syndrome Historic and Forecast Sales by Regions
• 8.8 Adenovirus Historic and Forecast Sales by Regions
• 8.9 Duck Viral Enteritis Historic and Forecast Sales by Regions
• 8.10 Inclusion Body Hepatitis Historic and Forecast Sales by Regions
• 8.11 Coccidiosis Historic and Forecast Sales by Regions
• 8.12 Avian Influenza Historic and Forecast Sales by Regions
• 8.13 Marek's Disease Historic and Forecast Sales by Regions
• 8.14 Newcastle Disease Historic and Forecast Sales by Regions
• 8.15 Salmonella Historic and Forecast Sales by Regions
• 8.16 Avian Encephalomyelitis Historic and Forecast Sales by Regions
• 8.17 Fowl Cholera Historic and Forecast Sales by Regions

9 . GLOBAL POULTRY VACCINES MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East Africa by Segment Sales Analysis
  • 9.7.3. Middle East Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE POULTRY VACCINES COMPANIES

• 10.1. Poultry Vaccines Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF POULTRY VACCINES INDUSTRY

• 11.1. Top 10 Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Boehringer Ingelheim International GmbH
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Ceva
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Zoetis
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Elanco
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Intervet Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Merck Co. Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Hester Biosciences Limited
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Vaxxinova International BV
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Venkys India
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. Calier
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments
• 11.13. KM Biologics
  • 11.13.1. Company Overview
  • 11.13.2. Company Revenue
  • 11.13.3. Products
  • 11.13.4. Recent Developments
• 11.14. Phibro Animal Health Corporation
  • 11.14.1. Company Overview
  • 11.14.2. Company Revenue
  • 11.14.3. Products
  • 11.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies